Tales of Transformation: A Life Sciences and Health Care Podcast Series
This Deloitte podcast series explores trends transforming life sciences and health care. Tune in to stay a step ahead of the trends shaping the industry.
This Deloitte podcast series explores trends transforming life sciences and health care. Tune in to stay a step ahead of the trends shaping the industry.
SalioGen’s lipid nanoparticle delivery of bioengineered mammalian transposases can integrate large genes at precise genomic locations.
Protein-truncating variants escaping nonsense-mediated decay (PTVescs) are often overlooked in genetic disease. We examined individuals with neurodevelopmental disorders referred for clinical exome sequencing for gene-level…
KateTx debuted less than a year ago with a $51 million Series A round co-led by Westlake Village BioPartners and Versant Ventures.
Novo Nordisk and Metaphore Biotechnologies will partner to develop obesity management treatments in an up-to-$600 million-plus collaboration.
The Francis Crick Institute is partnering to develop novel applications for Broken String’s DNA break-mapping platform, INDUCE-seq, to investigate the impact of genomic instability in…
Verve Therapeutics starts Phase I trial of its second base editing candidate therapy designed to target the PCSK9 gene.
A noninvasive, multitarget stool RNA test called ColoSense has been approved by the FDA to test for colorectal cancer.
MacroGenics (MGNX) shares cratered 77% after the company acknowledged the deaths of five patients in a clinical trial.
Two types of B cell in the tumor microenvironment modulate antitumor immunity
We catch up with Mammoth Biosciences CSO Lucas Harrington after his ASGCT presentation. Harrington lays out his company’s big plans in developing a range of…